Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs. Fiebiger BM, Maamary J, Pincetic A, Ravetch JV Proc Natl Acad Sci U S A. 2015 Apr 13. PMID: 25870292. Abstract CommentRecommendBookmarkWatch